We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Otsuka Presses Federal Judge to Block Generic Abilify as April 20 Exclusivity Deadline Nears
Otsuka Presses Federal Judge to Block Generic Abilify as April 20 Exclusivity Deadline Nears
Otsuka is again urging a federal judge in Maryland to prevent the FDA from granting any ANDA for generic versions of Abilify, after the agency indicated this week it had not yet decided whether the blockbuster antipsychotic drug’s exclusivity bars generic approvals.